Non-inferiority of ceftaroline fosamil was defined as a lower limit of the two-sided 95 % CI for the difference in the proportion of patients clinically cured of -10 % or higher ; if non-inferiority was achieved , superiority was to be concluded if the lower limit of the 95 % CI was greater than 0 % .